Walcott Brian P, Sivarajan Ganesh, Bashinskaya Bronislava, Anderson Douglas E, Leonetti John P, Origitano Thomas C
Neurosurgical Service, Massachusetts General Hospital, Boston, USA.
J Neurosurg Pediatr. 2009 Aug;4(2):125-9. doi: 10.3171/2009.3.PEDS08434.
Vestibular schwannomas (VSs) are rare in the pediatric population. Most often, these lesions manifest as a bilateral disease process in the setting of neurofibromatosis Type 2. Even in the absence of additional clinical diagnostic criteria, the presentation of a unilateral VS in a young patient may be a harbinger of future penetrance for this hereditary tumor syndrome.
The authors retrospectively reviewed the charts of a cohort of 7 patients who presented with apparently sporadic, unilateral VSs. These patients had previously undergone surgery via translabyrinthine, retrosigmoid, or combined approaches. Clinical outcomes were reviewed with emphasis on facial nerve function and follow-up for signs and symptoms of a heritable disorder.
All patients underwent microsurgical resection in a multidisciplinary effort by the senior authors. The average tumor size was 4.57 cm, with an average duration of symptoms prior to definitive diagnosis of 31.2 months. The tumor size at the time of presentation followed a trend different from reports in adults, while the duration of symptoms did not. At a follow-up average of 6.3 years (range 1-12 years), 100% of patients demonstrated good facial function (House-Brackmann Grade I or II). No patient in this cohort demonstrated symptoms, objective signs, or genetic analysis indicating the presence of neurofibromatosis Type 2.
Diagnosis and management of sporadic, unilateral VSs in children is complicated by clinical presentations and surgical challenges unique from their adult counterparts. Careful consideration should be given to a heritable genetic basis for sporadic unilateral VS in the pediatric population. Results of genetic testing do not preclude the necessity for long-term follow-up and systemic investigation. In patients who present with large tumors, preliminary experience leads the authors to suggest that a combined retrosigmoid-translabyrinthine approach offers the greatest opportunity for preservation of facial nerve function.
前庭神经鞘瘤(VSs)在儿科人群中较为罕见。这些病变最常表现为2型神经纤维瘤病背景下的双侧疾病过程。即使没有额外的临床诊断标准,年轻患者出现单侧VS也可能是这种遗传性肿瘤综合征未来发病的先兆。
作者回顾性分析了7例表现为明显散发性单侧VS患者的病历。这些患者此前已通过经迷路、乙状窦后或联合入路接受手术。回顾临床结果,重点关注面神经功能以及对遗传性疾病体征和症状的随访情况。
所有患者均在资深作者的多学科努力下接受了显微手术切除。肿瘤平均大小为4.57厘米,确诊前症状平均持续时间为31.2个月。就诊时的肿瘤大小呈现出与成人报告不同的趋势,而症状持续时间则没有。平均随访6.3年(范围1 - 12年)时,100%的患者面神经功能良好(House - Brackmann分级I或II级)。该队列中没有患者表现出提示2型神经纤维瘤病存在的症状、客观体征或基因分析结果。
儿童散发性单侧VS的诊断和管理因临床表现和手术挑战与成人不同而变得复杂。应仔细考虑儿科人群中散发性单侧VS的遗传基础。基因检测结果并不排除长期随访和系统检查的必要性。对于出现大肿瘤的患者,初步经验使作者建议乙状窦后 - 经迷路联合入路为保留面神经功能提供了最大机会。